Related Experiment Video
Updated: Dec 17, 2025
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
2.9K
Update on House Dust Mite Allergen Avoidance Measures for Asthma.
Chiara Zuiani1, Adnan Custovic2,3
1Imperial College Healthcare NHS Trust, London, UK.
Current Allergy and Asthma Reports
|June 21, 2020
Summary
House dust mite (HDM) allergen avoidance may help asthma patients. Recent evidence suggests impermeable bed encasings reduce severe asthma exacerbations, supporting a pragmatic, multifaceted approach to reduce exposure.
Area of Science:
- Allergy and Immunology
- Respiratory Medicine
- Environmental Health
Background:
- House dust mite (HDM) allergen avoidance strategies for asthma lack consensus.
- Previous systematic reviews and meta-analyses show mixed results on efficacy.
- Limitations in existing analyses may hinder clinical recommendations.
Purpose of the Study:
- To critically review evidence for and against HDM allergen avoidance in asthma patients.
- To evaluate the utility of current evidence for clinical recommendations.
- To provide guidance on pragmatic approaches to HDM allergen avoidance.
Main Methods:
- Critical review of existing scientific literature.
- Analysis of systematic reviews and meta-analyses.
- Inclusion of recent high-quality randomized controlled trials.
Main Results:
- Recent trials indicate impermeable bed encasings reduce emergency hospitalizations for severe asthma exacerbations in children.
- Existing meta-analyses have limitations and may not reflect current evidence accurately.
- No definitive consensus exists, but some measures show promise.
Conclusions:
- A pragmatic, multifaceted approach to HDM allergen avoidance is suggested.
- Physicians should advise sensitized patients to minimize exposure.
- Early intervention and assessment of sensitization/exposure status are recommended.
Related Concept Videos
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:20Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:26Asthma-II: Pathophysiology and Classification
3.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K